Trial Profile
Long-acting Beta Agonist Step Down Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms LASST
- 26 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Jun 2015 to 1 Oct 2015.
- 01 Sep 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Jun 2015 to 1 Oct 2015.